Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: a randomized, controlled trial

Hemalatha Rajkumar, Naseha Mahmood, Manoj Kumar, Sudarshan Reddy Varikuti, Hanumanth Reddy Challa, Shiva Prakash Myakala, Hemalatha Rajkumar, Naseha Mahmood, Manoj Kumar, Sudarshan Reddy Varikuti, Hanumanth Reddy Challa, Shiva Prakash Myakala

Abstract

To evaluate the effects of probiotic (VSL#3) and omega-3 fatty acid on insulin sensitivity, blood lipids, and inflammation, we conducted a clinical trial in 60 overweight (BMI > 25), healthy adults, aged 40-60 years. After initial screening the subjects were randomized into four groups with 15 per group. The four groups received, respectively, placebo, omega-3 fatty acid, probiotic VSL#3, or both omega-3 and probiotic, for 6 weeks. Blood and fecal samples were collected at baseline and after 6 weeks. The probiotic (VSL#3) supplemented group had significant reduction in total cholesterol, triglyceride, LDL, and VLDL and had increased HDL (P < 0.05) value. VSL#3 improved insulin sensitivity (P < 0.01), decreased hsCRP, and favorably affected the composition of gut microbiota. Omega-3 had significant effect on insulin sensitivity and hsCRP but had no effect on gut microbiota. Addition of omega-3 fatty acid with VSL#3 had more pronounced effect on HDL, insulin sensitivity and hsCRP. Subjects with low HDL, insulin resistance, and high hsCRP had significantly lower total lactobacilli and bifidobacteria count and higher E. coli and bacteroides count.

References

    1. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. The New England Journal of Medicine. 2000;342(12):836–843.
    1. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circulation Research. 2001;89(9):763–771.
    1. Faloia E, Michetti G, de Robertis M, Luconi MP, Furlani G, Boscaro M. Inflammation as a link between obesity and metabolic syndrome. Journal of Nutrition and Metabolism. 2012;2012:7 pages.476380
    1. WHO. Fact Sheet N°311. Geneva, Switzerland: WHO; 2013. Obesity and overweight. .
    1. Bhalwar R. Text Book of Public Health and Community Medicine. 1st edition. Pune, India: Department of Community Medicine, AFMC; 2009.
    1. Koenig W, Sund M, Fröhlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg cohort study, 1984 to 1992. Circulation. 1999;99(2):237–242.
    1. Pepys MB, Rowe IF, Baltz ML. C-Reactive protein: binding to lipids and lipoproteins. International Review of Experimental Pathology. 1985;27:83–111.
    1. Rohde LEP, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. American Journal of Cardiology. 1999;84(9):1018–1022.
    1. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. Journal of Clinical Investigation. 1995;95(5):2409–2415.
    1. Purohit A, Ghilchik MW, Duncan L, et al. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. Journal of Clinical Endocrinology and Metabolism. 1995;80(10):3052–3058.
    1. Baumann H, Gauldie J. The acute phase response. Immunology Today. 1994;15(2):74–80.
    1. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Annals of Internal Medicine. 1998;128(2):127–137.
    1. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19(4):972–978.
    1. Jones ML, Martoni CJ, Parent M, Prakash S. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. British Journal of Nutrition. 2012;107(10):1505–1513.
    1. Kumar M, Rakesh S, Nagpal R, et al. Probiotic Lactobacillus rhamnosus GG and Aloe vera gel improve lipid profiles in hypercholesterolemic rats. Nutrition. 2013;29(3):574–579.
    1. Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology. 2003;37(2):343–350.
    1. Tai CC, Ding ST. N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention. Journal of Nutritional Biochemistry. 2010;21(5):357–363.
    1. Root Martin, Collier SR, Zwetsloot KA, West KL, McGinn MC. A randomized trial of fish oil omega-3 fatty acids on arterial health, inflammation, and metabolic syndrome in a young healthy population. Nutrition Journal. 2013;12, article 1
    1. Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. Journal of Nutritional Biochemistry. 2010;21(9):781–792.
    1. Bays HE, Tighe AP, Sadovsky R, Davidson MH. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert Review of Cardiovascular Therapy. 2008;6(3):391–409.
    1. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. 1972;18(6):499–502.
    1. Matthews DR, Hosker JP, Rudenski AS. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419.
    1. Anderson JW, Gilliland SE. Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. Journal of the American College of Nutrition. 1999;18(1):43–50.
    1. Xiao JZ, Kondo S, Takahashi N, et al. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. Journal of Dairy Science. 2003;86(7):2452–2461.
    1. Kießling G, Schneider J, Jahreis G. Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. European Journal of Clinical Nutrition. 2002;56(9):843–849.
    1. Bukowska H, Pieczul-Mroz J, Jastrzebska M, Chelstowski K, Naruszewicz M. Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis. 1998;137(2):437–438.
    1. Naruszewicz M, Johansson M-L, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. American Journal of Clinical Nutrition. 2002;76(6):1249–1255.
    1. Hatakka K, Mutanen M, Holma R, Saxelin M, Korpela R. Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp shermanii JS administered in capsules is ineffective in lowering serum lipids. Journal of the American College of Nutrition. 2008;27(4):441–447.
    1. Simons LA, Amansec SG, Conway P. Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutrition, Metabolism and Cardiovascular Diseases. 2006;16(8):531–535.
    1. Lewis SJ, Burmeister S. A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids. European Journal of Clinical Nutrition. 2005;59(6):776–780.
    1. Kumar R, Rajkumar H, Kumar M, et al. Molecular cloning, characterization and heterologous expression of bile salt hydrolase (Bsh) from Lactobacillus fermentum NCDO394. Molecular Biology Reports. 2013;40(8):5057–5066.
    1. Kumar M, Nagpal R, Kumar R, et al. Cholesterol lowering probiotics as potential biotherapeutics for metabolic diseases. Experimental Diabetes Research. 2012;2012:14 pages.902917
    1. Nordgaard I, Mortensen PB, Langkilde AM. Small intestinal malabsorption and colonic fermentation of resistant starch and resistant peptides to short-chain fatty acids. Nutrition. 1995;11(2):129–137.
    1. Venter CS, Vorster HH. Possible metabolic consequences of fermentation in the colon for humans. Medical Hypotheses. 1989;29(3):161–166.
    1. Phillipson BE, Rothrock DW, Connor WE. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. The New England Journal of Medicine. 1985;312(19):1210–1216.
    1. Harris WS, Connor WE, Illingworth DR, Rothrock DW, Foster DM. Effects of fish oil on VLDL triglyceride kinetics in humans. Journal of Lipid Research. 1990;31(9):1549–1558.
    1. Nestel PJ, Connor WE, Reardon MF. Suppression by diets rich in fish oil of very low density lipoprotein production in man. Journal of Clinical Investigation. 1984;74(1):82–89.
    1. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. 2012;28(5):539–543.
    1. Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T. Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-A(y) mice. Endocrine Journal. 1997;44(3):357–365.
    1. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. Journal of the American Medical Association. 1999;282(22):2131–2135.
    1. Cani PD, Delzenne NM, Amar J, Burcelin R. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathologie Biologie. 2008;56(5):305–309.
    1. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. Journal of Clinical Investigation. 2011;121(6):2126–2132.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir